The price of SAP shares increased by 1.6 percent, reaching EUR 170.50, which brought the company's market capitalization to ...
Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...
The United Laboratories International Holdings Limited and Novo Nordisk (NVO) announced earlier that Novo Nordisk and TUL’s wholly-owned ...
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...
Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...
Novo Nordisk said yesterday that it’s licensed a new obesity drug from The United Laboratories, a Chinese drugmaker.
1d
Pharmaceutical Technology on MSNNovo Nordisk earmarks $2bn for Chinese “triple G” weight loss shotNovo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...
SAP's journey began in 1972 when five former IBM employees founded the company in Germany. Initially focused on business ...
Merck last year signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to ...
The pivot to the cloud has led to a big rally in SAP stock.
The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...
SAP surpasses Novo Nordisk as Europes most valuable corporation at 500 trillion won SAP races to the forefront of European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results